Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Glynn

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based MethodsNatalia Kunst, Edward C F Wilson, David Glynn, et al.
BMJ Open|May 19, 2025
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation interventionDavid Glynn, Pedro Saramago, Naveed Ahmed, et al.
Health Technology Assessment (Winchester, England)|November 22, 2023
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCTAdrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Health Technology Assessment (Winchester, England)|January 6, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-frameworkPeter Murphy, David Glynn, Sofia Dias, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 17, 2020
Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based MethodsNatalia Kunst, Edward C F Wilson, David Glynn, et al.
BMJ Open|May 19, 2025
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation interventionDavid Glynn, Pedro Saramago, Naveed Ahmed, et al.
Health Technology Assessment (Winchester, England)|November 22, 2023
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCTAdrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
Pageof 4